112 related articles for article (PubMed ID: 24583918)
1. Increased serum level of soluble vascular endothelial growth factor receptor-1 is associated with poor coronary collateralization in patients with stable coronary artery disease.
Sun Z; Shen Y; Lu L; Zhang RY; Pu LJ; Zhang Q; Yang ZK; Hu J; Chen QJ; Shen WF
Circ J; 2014; 78(5):1191-6. PubMed ID: 24583918
[TBL] [Abstract][Full Text] [Related]
2. Serum Cystatin C Reflects Angiographic Coronary Collateralization in Stable Coronary Artery Disease Patients with Chronic Total Occlusion.
Shen Y; Ding FH; Zhang RY; Zhang Q; Lu L; Shen WF
PLoS One; 2015; 10(9):e0137253. PubMed ID: 26402227
[TBL] [Abstract][Full Text] [Related]
3. Impact of type 2 diabetes on the plasma levels of vascular endothelial growth factor and its soluble receptors type 1 and type 2 in patients with peripheral arterial disease.
Wieczór R; Gadomska G; Ruszkowska-Ciastek B; Stankowska K; Budzyński J; Fabisiak J; Suppan K; Pulkowski G; Rość D
J Zhejiang Univ Sci B; 2015 Nov; 16(11):948-56. PubMed ID: 26537213
[TBL] [Abstract][Full Text] [Related]
4. Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer.
Chang YT; Chang MC; Wei SC; Tien YW; Hsu C; Liang PC; Tsao PN; Jan IS; Wong JM
Pancreas; 2008 Aug; 37(2):145-50. PubMed ID: 18665074
[TBL] [Abstract][Full Text] [Related]
5. Association of serum mimecan with angiographic coronary collateralization in patients with stable coronary artery disease and chronic total occlusion.
Shen Y; Ding FH; Zhang RY; Zhang Q; Lu L; Shen WF
Atherosclerosis; 2016 Sep; 252():75-81. PubMed ID: 27508318
[TBL] [Abstract][Full Text] [Related]
6. Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion.
Shen Y; Lu L; Ding FH; Sun Z; Zhang RY; Zhang Q; Yang ZK; Hu J; Chen QJ; Shen WF
Cardiovasc Diabetol; 2013 Nov; 12():165. PubMed ID: 24209601
[TBL] [Abstract][Full Text] [Related]
7. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia.
Ahmad S; Ahmed A
Circ Res; 2004 Oct; 95(9):884-91. PubMed ID: 15472115
[TBL] [Abstract][Full Text] [Related]
8. PlGF and sVEGFR-1 in chronic subdural hematoma: implications for hematoma development.
Kalamatianos T; Stavrinou LC; Koutsarnakis C; Psachoulia C; Sakas DE; Stranjalis G
J Neurosurg; 2013 Feb; 118(2):353-7. PubMed ID: 23140147
[TBL] [Abstract][Full Text] [Related]
9. An elevated ratio of placental growth factor to soluble fms-like tyrosine kinase-1 predicts adverse outcomes in patients with stable coronary artery disease.
Matsumoto T; Uemura S; Takeda Y; Matsui M; Okada S; Nishida T; Soeda T; Okayama S; Somekawa S; Ishigami K; Onoue K; Kawata H; Kawakami R; Horii M; Saito Y
Intern Med; 2013; 52(10):1019-27. PubMed ID: 23676585
[TBL] [Abstract][Full Text] [Related]
10. The relationship between the VEGF/sVEGFR-1 ratio and threatened abortion.
Keskin U; Ulubay M; Dede M; Ozgurtas T; Koçyiğit YK; Aydin FN; Ergün A
Arch Gynecol Obstet; 2015 Mar; 291(3):557-61. PubMed ID: 25200689
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast.
Munaut C; Lorquet S; Pequeux C; Blacher S; Berndt S; Frankenne F; Foidart JM
Hum Reprod; 2008 Jun; 23(6):1407-15. PubMed ID: 18413304
[TBL] [Abstract][Full Text] [Related]
12. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin.
Bujold E; Romero R; Chaiworapongsa T; Kim YM; Kim GJ; Kim MR; Espinoza J; Gonçalves LF; Edwin S; Mazor M
J Matern Fetal Neonatal Med; 2005 Jul; 18(1):9-16. PubMed ID: 16105786
[TBL] [Abstract][Full Text] [Related]
13. Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia.
Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y
J Clin Endocrinol Metab; 2007 Jul; 92(7):2672-9. PubMed ID: 17426083
[TBL] [Abstract][Full Text] [Related]
14. Reduced serum vascular endothelial growth factor receptor-2 (sVEGFR-2) and sVEGFR-1 levels in gastric cancer patients.
Kikuchi S; Obata Y; Yagyu K; Lin Y; Nakajima T; Kobayashi O; Kikuichi M; Ushijima R; Kurosawa M; Ueda J
Cancer Sci; 2011 Apr; 102(4):866-9. PubMed ID: 21219538
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus.
Robak E; Sysa-Jedrzejewska A; Robak T
Mediators Inflamm; 2003 Oct; 12(5):293-8. PubMed ID: 14760936
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences.
Tsatsaris V; Goffin F; Munaut C; Brichant JF; Pignon MR; Noel A; Schaaps JP; Cabrol D; Frankenne F; Foidart JM
J Clin Endocrinol Metab; 2003 Nov; 88(11):5555-63. PubMed ID: 14602804
[TBL] [Abstract][Full Text] [Related]
17. Clinical and angiographic features associated with coronary collateralization in stable angina patients with chronic total occlusion.
Sun Z; Shen Y; Lu L; Zhang RY; Pu LJ; Zhang Q; Yang ZK; Hu J; Chen QJ; Shen WF
J Zhejiang Univ Sci B; 2013 Aug; 14(8):705-12. PubMed ID: 23897789
[TBL] [Abstract][Full Text] [Related]
18. Serum placental growth factor, vascular endothelial growth factor, soluble vascular endothelial growth factor receptor-1 and -2 levels in periodontal disease, and adverse pregnancy outcomes.
Sert T; Kırzıoğlu FY; Fentoğlu O; Aylak F; Mungan T
J Periodontol; 2011 Dec; 82(12):1735-48. PubMed ID: 21513467
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated gene transfer of placental growth factor to perivascular tissue induces angiogenesis via upregulation of the expression of endogenous vascular endothelial growth factor-A.
Roy H; Bhardwaj S; Babu M; Jauhiainen S; Herzig KH; Bellu AR; Haisma HJ; Carmeliet P; Alitalo K; Ylä-Herttuala S
Hum Gene Ther; 2005 Dec; 16(12):1422-8. PubMed ID: 16390273
[TBL] [Abstract][Full Text] [Related]
20. Reduced coronary collateralization in type 2 diabetic patients with chronic total occlusion.
Shen Y; Ding FH; Dai Y; Wang XQ; Zhang RY; Lu L; Shen WF
Cardiovasc Diabetol; 2018 Feb; 17(1):26. PubMed ID: 29422093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
